Myocardial perfusion imaging is an imaging device which work non-invasively to show the blood flow, myocardial perfusion imaging also known as nuclear cardiology test. The main function of this imaging to show the blood flow to muscle of heart or myocardium and to identify the absence or presence of CAD (coronary artery disease). Myocardial perfusion imaging show 3D image. Myocardial perfusion imaging two technique, such as PET (positron emission tomography) and SPECT (single photon emission computed tomography). Myocardial perfusion imaging is useful in checking of chest discomfort for facing problem in blood flow to muscle of heart that is caused by angina (blocked in heart arteries) or by narrow in the arteries vessels. The myocardial perfusion imaging process as a small amount of radioactive material is injected that can travel to muscle of heart, then the scan process started to monitor the flow. The Myocardial perfusion imaging testing manage to treat the CAD (coronary artery disease) for medical therapy and revascularization process.
Get Free Sample Copy With Impact Analysis Of COVID-19 Of Market Report @ https://www.persistencemarketresearch.com/samples/17758
Myocardial Perfusion Imaging (MPI) Testing Market: Drivers & Restraints
Myocardial perfusion imaging is a growing market over the forecast period, as per WHO report published in September 2016, about 17 million people die from CVD (cardiovascular disease), players are also working on new technology are also under innovation to make the process to be simple for the examination and reimbursement regulation, as Cardinal Health has published a guideline for reimbursement for Myocardial perfusion imaging, under CPT of 93015, 93016 and others. The high costing of the test and lack of availability of the devices is the current hindrances of myocardial perfusion imaging and the awareness about the test in developing country is also the prohibiting the growth of myocardial perfusion imaging testing market.
Myocardial Perfusion Imaging (MPI) Testing Market: Segmentation
Myocardial perfusion imaging testing market is segmented based on:
Based on product type:
Based on End User:
- Ambulatory Surgery Center
You Can Buy This PMR Healthcare Report From Here @ https://www.persistencemarketresearch.com/checkout/17758
Myocardial Perfusion Imaging (MPI) Testing is useful for heart checkups to monitor the flow of blood in myocardium, the market of myocardial perfusion imaging (MPI) testing is growing as the health awareness is growing and various activity are take place by various NGO. Myocardial Perfusion Imaging (MPI) Testing accurately measure the flow of blood and show the blockage in arteries and also find the injury in heart. Apart from some side effect of myocardial perfusion imaging (MPI) testing, such as chest pain, pain in arms and back and other side effect the market of myocardial perfusion imaging (MPI) testing is growing, as the test results are accurate and provide the details information about the heart. Furthermore enhancements are going on the device and the method of checking, such as details information of anatomic and function and players are coming with new technology to resolve the side effects.
As a geography conditions the Myocardial Perfusion Imaging (MPI) Testing Market is segmented into: North America, Latin America, Europe, Asia-Pacific and the Middle East & Africa. North America is holding the major segment of the market, according to CDC (center for disease control and prevention) published report on August 2015, every year about 735,000 Americans have a heart attack from this 525,000 are having first heart attack and 210,000 people have heart attack who have already had a heart attack in pervious history. Europe and Asia Pacific is also growing market for myocardial perfusion imaging (MPI) testing and the awareness is increasing.
Some players in Myocardial Perfusion Imaging (MPI) Testing Market as Siemens Ltd., Koninklijke Philips N.V., Convergent Imaging Solutions, SurgicEye GmbH, Lantheus Medical Imaging, Inc. and Spectrum Dynamics Medical.